Laboratory of Exercise Biochemistry and Physiology, Postgraduate Program in Health Sciences, Health Sciences Unit, Universidade do Extremo Sul Catarinense, 88806-000, Criciúma, SC, Brazil.
Laboratory of Autoimmunity and Immunopharmacology, Campus Araranguá, Universidade Federal de Santa Catarina, Rodovia Jorge Lacerda, Km 35,4-Jardim das Avenidas, 88900-000, Araranguá, SC, Brazil.
Mol Neurobiol. 2017 Aug;54(6):4723-4737. doi: 10.1007/s12035-016-0014-0. Epub 2016 Jul 22.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) caused by demyelination, immune cell infiltration, and axonal damage. Herein, we sought to investigate the influence of physical exercise on mice experimental autoimmune encephalomyelitis (EAE), a reported MS model. Data show that both strength and endurance training protocols consistently prevented clinical signs of EAE and decreased oxidative stress, an effect which was likely due to improving genomic antioxidant defense-nuclear factor erythroid 2-related factor (Nrf2)/antioxidant response elements (ARE) pathway-in the CNS. In addition, physical exercise inhibited the production of pro-inflammatory cytokines interferon (IFN)-γ, interleukin (IL)-17, and IL-1β in the spinal cord of mice with EAE. Of note, spleen cells obtained from strength training group incubated with MOG showed a significant upregulation of CD25 and IL-10 levels, with a decrease of IL-6, MCP-1, and tumor necrosis factor (TNF)-α production, mainly, during acute and chronic phase of EAE. Moreover, these immunomodulatory effects of exercise were associated with reduced expression of adhesion molecules, especially of platelet and endothelial cell adhesion molecule 1 (PECAM-1). Finally, physical exercise also restored the expression of tight junctions in spinal cord. Together, these results demonstrate that mild/moderate physical exercise, when performed regularly in mice, consistently attenuates the progression and pathological hallmarks of EAE, thereby representing an important non-pharmacological intervention for the improvement of immune-mediated diseases such as MS. Graphical Abstract Schematic diagram illustrating the beneficial effects of physical exercise during experimental model of MS. Physical exercise, especially strength (ST) and endurance (ET) training protocols, inhibits the development and progression of disease, measured by the mean maximal clinical score (1.5 and 1.0, respectively), with inhibition of 30 % and 50 %, respectively, based on the AUC, compared with EAEuntreated group. In addition, ST and ET decreased oxidative stress, possibly, through genomic antioxidant defense, Nrf2-Keap1 signaling pathway, in the CNS. Physical exercise inhibited the production of inflammatory cytokines, such as IFN-γ, IL-17 and IL-1β in the spinal cord after EAE induction, as well as spleen cells obtained from ST group showed a significant upregulation of regulatory T cell markers, such as CD25 and IL-10 levels, and blocked IL-6, MCP-1 and TNF-α production, mainly, during acute and chronic phase of EAE. Finally, these immunomodulatory effects of exercise were associated with inhibition of adhesion molecules and reestablishment of tight junctions expression in spinal cord tissue, thereby limiting BBB permeability and transmigration of autoreactive T cells to the CNS. NO, nitric oxide; GPx, glutathione peroxidase, GSH, glutathione; Nrf2, nuclear factor (erythroid-derived 2)-like 2; CNS, central nervous system; BBB, blood-brain barrier; IFN-g, interferon-gamma; IL-17, interleukin 17; IL-1b, interleukin-1beta.
多发性硬化症(MS)是一种中枢神经系统(CNS)的慢性炎症性疾病,由脱髓鞘、免疫细胞浸润和轴突损伤引起。在此,我们研究了运动对实验性自身免疫性脑脊髓炎(EAE),一种报道的 MS 模型的影响。数据表明,力量和耐力训练方案都能预防 EAE 的临床症状,并降低氧化应激,这可能是由于改善了 CNS 中的基因组抗氧化防御-核因子红细胞 2 相关因子(Nrf2)/抗氧化反应元件(ARE)途径。此外,运动抑制了 EAE 小鼠脊髓中促炎细胞因子干扰素(IFN)-γ、白细胞介素(IL)-17 和 IL-1β的产生。值得注意的是,来自力量训练组的脾细胞与 MOG 孵育后,CD25 和 IL-10 水平显著上调,IL-6、单核细胞趋化蛋白-1(MCP-1)和肿瘤坏死因子(TNF)-α的产生减少,主要在 EAE 的急性和慢性阶段。此外,运动的这些免疫调节作用与粘附分子的表达减少有关,特别是血小板和内皮细胞粘附分子 1(PECAM-1)。最后,运动还恢复了脊髓中紧密连接的表达。总之,这些结果表明,在小鼠中定期进行轻度/中度运动可一致减轻 EAE 的进展和病理特征,因此是改善多发性硬化症等免疫介导性疾病的重要非药物干预措施。